Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03275181 | Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer | completed | — | 18 | Kansas State UniversityOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT01368055 | Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer(PR07) | completed | N/A | 361 | University of FloridaOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT04576871 | Re-treatment 225Ac-J591 for mCRPC | completed | Early Phase 1 | 6 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT02874014 | Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer | completed | Phase 2 | 56 | Mayo ClinicOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07134504 | Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. | completed | — | 1 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Aug 21, 2025 | clinicaltrials |
| NCT05533515 | Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer(C-ProMeta-1) | completed | — | 330 | Queen Mary University of LondonOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06281769 | Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision | completed | N/A | 467 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT04666129 | Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 48 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Aug 17, 2025 | clinicaltrials |
| NCT04301414 | Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer(Neo-Red-P) | completed | Early Phase 1 | 26 | Columbia UniversityOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05137561 | Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP)(PROBIOP) | completed | Phase 2 / Phase 3 | 217 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05585034 | Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors | completed | Phase 1 | 60 | Xencor, Inc.INDUSTRY | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05764330 | Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance | completed | N/A | 20 | Roswell Park Cancer InstituteOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT05176756 | RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)(ALLSTAR) | completed | N/A | 150 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT02975934 | A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency(TRITON3) | completed | Phase 3 | 405 | pharmaand GmbHINDUSTRY | 12 | Jul 25, 2025 | clinicaltrials |
| NCT05458856 | Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate(TriptoSwitch) | completed | Phase 3 | 147 | IpsenINDUSTRY | 7 | Jul 25, 2025 | clinicaltrials |
| NCT02425592 | Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)(ASPIRE) | completed | — | 223 | Yale UniversityOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT05544227 | Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 15 | Williams Cancer FoundationOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT03199586 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | completed | Phase 1 | 23 | Novita Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05547386 | 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 163 | Mayo ClinicOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT03448458 | Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 2 | 17 | Emory UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT02430480 | Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2025 | clinicaltrials |
| NCT03963739 | Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer(PCW) | completed | — | 255 | Wake Forest University Health SciencesOTHER | 2 | Jul 16, 2025 | clinicaltrials |
| NCT07069465 | Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging(PIONEER PSMA) | completed | Early Phase 1 | 10 | Urology Clinics of North TexasNETWORK | 1 | Jul 16, 2025 | clinicaltrials |
| NCT04742361 | Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer | completed | Phase 3 | 136 | ABX advanced biochemical compounds GmbHINDUSTRY | 3 | Jul 15, 2025 | clinicaltrials |
| NCT05877144 | LiSWT for Nerve Sparing Radical Prostatectomy ED | completed | N/A | 8 | Thomas Jefferson UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT02242773 | MRI Based Active Selection for Treatment Trial(MAST) | completed | N/A | 208 | University of MiamiOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT04827446 | Lighting Intervention for Cancer-related Fatigue | completed | N/A | 139 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT00923104 | An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin | completed | — | 61 | National Cancer Institute (NCI)NIH | 1 | Jul 8, 2025 | clinicaltrials |
| NCT03162003 | Irish Programme for Stratified Prostate Cancer Therapy(iPROSPECT) | completed | — | 55 | Cancer Trials IrelandNETWORK | 1 | Jul 8, 2025 | clinicaltrials |
| NCT04621500 | Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans(VitD/RNA-seq) | completed | Phase 2 | 60 | Medical University of South CarolinaOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT06902441 | Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database | completed | — | 52,000 | University Hospital, CaenOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT03741335 | GET FIT Prostate: A Randomized Controlled Exercise Trial | completed | N/A | 284 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03630354 | EXERCISING TOGETHER for Couples Coping With Cancer | completed | N/A | 496 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT06199986 | DeADT - Living Well With Prostate Cancer(DeADT-LW) | completed | N/A | 50 | University of MichiganOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT03315871 | Combination Immunotherapy in Biochemically Recurrent Prostate Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04400656 | PROState Pathway Embedded Comparative Trial(IP3-PROSPECT) | completed | — | 139 | Imperial College LondonOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT02903368 | Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy | completed | Phase 2 | 118 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT04100018 | A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer(CheckMate 7DX) | completed | Phase 3 | 1,030 | Bristol-Myers SquibbINDUSTRY | 28 | Jun 12, 2025 | clinicaltrials |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 84 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Jun 12, 2025 | clinicaltrials |
| NCT03072238 | Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer(IPATential150) | completed | Phase 3 | 1,101 | Hoffmann-La RocheINDUSTRY | 26 | Jun 6, 2025 | clinicaltrials |
| NCT00667069 | Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | completed | Phase 3 | 424 | UNICANCEROTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT02957149 | Platelet Rich Plasma During Radical Prostatectomy | completed | N/A | 24 | Mayo ClinicOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05735652 | An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel | completed | — | 14 | Boston Scientific CorporationINDUSTRY | 1 | May 30, 2025 | clinicaltrials |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | completed | Phase 1 / Phase 2 | 89 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | May 29, 2025 | clinicaltrials |
| NCT06312670 | Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer | completed | Phase 2 | 13 | Pedro Barata, MD, MScOTHER | 1 | May 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 2, 2025source: clinicaltrials